The effects of dietary supplementation with inulin and inulin‐propionate ester on hepatic steatosis in adults with non‐alcoholic fatty liver disease. Issue 2 (16th September 2018)
- Record Type:
- Journal Article
- Title:
- The effects of dietary supplementation with inulin and inulin‐propionate ester on hepatic steatosis in adults with non‐alcoholic fatty liver disease. Issue 2 (16th September 2018)
- Main Title:
- The effects of dietary supplementation with inulin and inulin‐propionate ester on hepatic steatosis in adults with non‐alcoholic fatty liver disease
- Authors:
- Chambers, Edward S.
Byrne, Claire S.
Rugyendo, Annette
Morrison, Douglas J.
Preston, Tom
Tedford, Catriona
Bell, Jimmy D.
Thomas, Louise
Akbar, Arne N.
Riddell, Natalie E.
Sharma, Rohini
Thursz, Mark R.
Manousou, Pinelopi
Frost, Gary - Abstract:
- Abstract : The short chain fatty acid (SCFA) propionate, produced through fermentation of dietary fibre by the gut microbiota, has been shown to alter hepatic metabolic processes that reduce lipid storage. We aimed to investigate the impact of raising colonic propionate production on hepatic steatosis in adults with non‐alcoholic fatty liver disease (NAFLD). Eighteen adults were randomized to receive 20 g/d of an inulin‐propionate ester (IPE), designed to deliver propionate to the colon, or an inulin control for 42 days in a parallel design. The change in intrahepatocellular lipid (IHCL) following the supplementation period was not different between the groups ( P = 0.082), however, IHCL significantly increased within the inulin‐control group (20.9% ± 2.9% to 26.8% ± 3.9%; P = 0.012; n = 9), which was not observed within the IPE group (22.6% ± 6.9% to 23.5% ± 6.8%; P = 0.635; n = 9). The predominant SCFA from colonic fermentation of inulin is acetate, which, in a background of NAFLD and a hepatic metabolic profile that promotes fat accretion, may provide surplus lipogenic substrate to the liver. The increased colonic delivery of propionate from IPE appears to attenuate this acetate‐mediated increase in IHCL.
- Is Part Of:
- Diabetes, obesity & metabolism. Volume 21:Issue 2(2019)
- Journal:
- Diabetes, obesity & metabolism
- Issue:
- Volume 21:Issue 2(2019)
- Issue Display:
- Volume 21, Issue 2 (2019)
- Year:
- 2019
- Volume:
- 21
- Issue:
- 2
- Issue Sort Value:
- 2019-0021-0002-0000
- Page Start:
- 372
- Page End:
- 376
- Publication Date:
- 2018-09-16
- Subjects:
- clinical trial -- dietary intervention -- fatty liver -- insulin resistance
Diabetes -- Periodicals
Obesity -- Periodicals
Metabolism -- Disorders -- Periodicals
Clinical pharmacology -- Periodicals
616.462 - Journal URLs:
- http://www.blackwellpublishing.com/journal.asp?ref=1462-8902&site=1 ↗
http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1463-1326 ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1111/dom.13500 ↗
- Languages:
- English
- ISSNs:
- 1462-8902
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3579.601970
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 13040.xml